Antares Pharma Inc.

Antares Pharma Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
157.44 M
Public Float
143.03 M
Antares Pharma Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.04
Market Cap
$551.28 M
Shares Outstanding
162.62 M
Public Float
142.55 M

Profile

Address
100 Princeton South
Ewing New Jersey 08628
United States
Employees -
Website http://www.antarespharma.com
Updated 07/08/2019
Antares Pharma, Inc. is a pharmaceutical company. The company focuses on the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Its activities include the development of injection devices and injection based pharmaceutical products as well as transdermal gel products.

Financials

View All
Created with Highcharts 5.0.14Antares Pharma Inc.Net Income. Fiscal year is January-December. All values USD Thousands.20 50620 50635 15135 15120 65820 65824 33824 33816 74316 7436 5156 515201320142015201620172018010k20k30k40k
Created with Highcharts 5.0.14Antares Pharma Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.20 61820 61826 50126 50145 65845 65852 22252 22254 51554 51563 55463 554201320142015201620172018020k40k60k80k

Robert F. Apple
President, Chief Executive Officer & Director
Leonard S. Jacob
Chairman